In the latest close session, Pfizer (PFE) was up +1.63% at $25.56. This move outpaced the S&P 500's daily loss of 0.53%. On the other hand, the Dow registered a loss of 0.09%, and the ...

Shares of Pfizer Inc. PFE rallied 1.71% to $25.58 Wednesday, on what proved to be an all-around poor trading session for the ...

Drugmaker CEOs see sales online channels as a budding opportunity, while some biotech investors told BioPharma Dive to expect ...

Sanofi Chief Executive Paul Hudson said on Wednesday the company is likely to see some weakness in U.S. vaccine demand this ...

We don’t have to go far to find a convincing explanation for President Donald Trump’s Jan. 3 attack in Venezuela; it’s transactionalism.

Seven S&P 500 high-yield 'safer' dividend stocks—like Ford, AT&T, and VICI—offer strong payouts supported by free cash flow ...

Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...

Find Latest Business News on Indian Economy,Top News on Monetary & Trade Policies, BSE & NSC Notices, Management Interviews & more .

Pfizer PFE stock has declined almost 5% in a month, losing $7.3 billion in market capitalization. Shares dipped recently ...

The global anti-infectives market size was US$ 117.54 billion in 2021. The global anti-infectives market is forecast to grow to US$ 209.25 billion by 2030 by growing at a compound annual growth rate ...

Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology ...

L3Harris shares climbed to a fresh high Tuesday after the defense contractor said it plans to spin off one of its divisions with backing from the federal government.